diseas
sinus
frequent
result
dysregul
immunolog
function
may
rang
infect
allerg
autoimmun
diseas
sinu
diseas
may
part
multisystem
system
condit
frequent
also
involv
nasal
passag
eye
upper
lower
airway
even
gastrointestin
tract
propos
part
human
airway
top
bottom
includ
nasal
passag
sinus
pharynx
bronchi
bronchiol
histomorpholog
makeup
corollari
theori
common
airway
uniformli
suscept
insult
diseas
process
diseas
lower
upper
respiratori
tract
therefor
intric
link
truth
alway
simpl
reason
interrelationship
diseas
may
simpli
base
singl
airway
theori
system
chang
immunolog
paradigm
individu
lifetim
exampl
immunolog
autoimmun
condit
affect
sinus
lower
airway
well
known
case
aspirinexacerb
respiratori
diseas
granulomatosi
polyangi
gpa
formerli
wegen
granulomatosi
immunolog
basi
lead
suscept
sinus
lower
airway
diseas
subject
ongo
research
epidemiolog
evid
connect
upper
lower
airway
abund
exampl
treatment
diseas
upper
airway
often
lead
clinic
improv
lower
airway
symptom
impact
upper
airway
inflamm
lower
airway
diseas
asthma
clearli
demonstr
mechan
interact
entir
clear
may
simpli
explain
similar
epitheli
line
two
structur
idea
common
featur
upper
lower
inflammatori
airway
diseas
describ
earliest
record
histori
medicin
condit
consist
asthma
describ
egyptian
record
medic
histori
year
ago
term
asthma
first
appear
greek
epic
work
iliad
homer
twelfth
centuri
maimonid
treatis
asthma
actual
describ
patient
whose
asthma
symptom
frequent
start
common
cold
j
bostock
describ
afflict
paper
period
affect
eye
chest
describ
condit
includ
sneez
farther
sensat
tight
chest
difficulti
breath
gener
irrit
fauc
trachea
thu
link
lower
upper
airway
charl
blackley
one
father
allergolog
describ
nasal
bronchial
symptom
exposur
pollen
grain
propos
proven
aspir
nasal
secret
could
lead
asthma
exacerb
theori
fact
never
proven
modern
studi
reveal
radiolabel
allergen
introduc
nose
found
way
lower
respiratori
system
digest
system
hand
discount
possibl
upper
airway
patholog
influenc
lower
airway
symptom
even
absenc
direct
contact
direct
transmiss
incit
agent
mechan
may
play
fh
bosworth
publish
articl
entitl
hay
fever
asthma
alli
affect
describ
function
nose
keep
tissu
moist
mucou
hydrat
also
address
hay
fever
hay
asthma
therebi
also
forg
link
upper
lower
airway
long
known
patient
allerg
rhiniti
higher
incid
asthma
vice
versa
rate
vari
region
region
comprehens
review
literatur
present
cruz
et
al
aria
report
describ
coexist
two
condit
almost
region
world
one
except
certain
area
china
asthmat
patient
describ
concurr
nasal
rhiniti
symptom
rate
asthma
rhiniti
patient
vice
versa
present
tabl
much
avail
data
impact
allerg
rhiniti
asthma
deriv
intern
studi
asthma
allergi
childhood
isaac
perenni
rhiniti
consid
risk
factor
nonatop
asthma
european
commun
respiratori
health
survey
evalu
subject
reveal
asthma
common
patient
atop
nonatop
individu
moreov
even
nonasthmat
patient
symptom
rhiniti
like
concurr
bronchial
hyperrespons
studi
rochest
minnesota
healthcar
cost
patient
concurr
asthma
allerg
rhiniti
found
higher
patient
asthma
alon
support
common
airway
principl
fact
nonallerg
respiratori
diseas
demonstr
associ
lower
upper
airway
diseas
process
bronchiectasi
cystic
fibrosi
primari
cilia
dyskinesia
defici
smoke
young
syndrom
concurr
upper
lower
airway
symptom
gener
increas
rate
asthma
past
year
accompani
increas
incid
allerg
rhiniti
modern
asian
countri
japan
preval
allerg
rhiniti
increas
report
aira
updat
preval
asthma
similarli
increas
poorer
countri
rate
still
much
lower
exampl
tibet
rate
allerg
rhiniti
current
wheez
asthma
respect
develop
countri
within
asia
rate
alreadi
start
rise
mimick
trend
alreadi
occur
develop
countri
preval
asthma
thailand
increas
preval
allerg
rhiniti
increas
studi
grass
allerg
patient
control
investig
exist
bronchial
hyperrespons
bhr
airway
inflamm
allerg
rhiniti
studi
author
use
bronchoprovoc
histamin
measur
exhal
nitric
oxid
exhal
breath
concentr
level
ph
evalu
presenc
airway
inflamm
allerg
patient
bhr
found
bhr
feno
level
increas
pollen
season
evid
link
rhiniti
asthma
present
studi
grass
allerg
patient
number
function
inflammatori
paramet
includ
nasal
airflow
eosinophil
level
measur
cytokin
profil
correl
airway
flow
present
upper
lower
airway
studi
establish
link
support
unifi
airway
concept
import
appreci
rhiniti
risk
factor
asthma
whether
rhiniti
allerg
natur
word
common
upper
lower
airway
respons
simpli
attribut
state
atopi
import
consider
discuss
pathogenesi
one
airway
one
diseas
concept
associ
rhinosinus
asthma
studi
result
vari
one
seri
patient
preval
asthma
allerg
rhiniti
chronic
sinus
nonallerg
rhiniti
patient
respect
sourc
estim
patient
chronic
rhinosinus
may
evid
asthma
convers
also
true
asthma
patient
may
evid
chronic
rhinosinus
morpholog
abnorm
sinus
also
report
occur
frequent
asthmat
swedish
studi
investig
relationship
symptom
asthma
chronic
rhinosinus
group
util
data
extract
west
sweden
asthma
studi
found
gener
popul
multisymptom
asthma
determin
symptom
chronic
rhinosinus
associ
higher
risk
multisymptom
asthma
rather
fewersymptom
asthma
moreov
found
incid
allerg
rhiniti
differ
multi
fewersymptom
asthma
group
rhinorrhea
nasal
congest
higher
multisystem
group
studi
subject
sever
steroiddepend
asthma
subject
mildtomoder
asthma
reveal
former
group
latter
group
also
symptom
sinonas
diseas
also
note
sever
asthmat
mildtomoder
asthmat
abnorm
ct
scan
ct
scan
clinic
score
appear
sever
sever
asthma
group
find
confirm
brink
et
al
discov
frequenc
abnorm
ct
scan
sever
asthma
patient
also
note
correl
sinus
sever
asthma
patient
sputum
eosinophilia
provid
addit
link
upper
lower
airway
correl
also
describ
marker
airway
inflamm
exhal
nitric
oxid
eno
sinu
ct
score
eno
level
nasal
polyp
estim
allerg
rhiniti
may
play
role
case
acut
sinus
may
significantli
greater
case
chronic
sinus
twentysix
percent
patient
rhinosinus
found
concomit
allerg
rhiniti
anoth
studi
allerg
rhiniti
patient
control
show
perenni
allerg
rhiniti
patient
evid
sinus
ct
scan
wherea
find
present
control
also
found
patient
chronic
rhinosinus
like
sensit
perenni
allergen
season
allergen
hand
examin
relationship
vitro
ige
sensit
allergen
atopi
degre
sever
rhinosinus
appear
signific
correl
chronic
rhinosinus
describ
persist
inflammatori
state
sinus
may
may
result
infecti
process
bacteria
virus
infect
sinus
common
bacteria
found
sinus
among
immunocompet
host
includ
haemophilu
influenza
moraxella
catarrhali
streptococcu
pneumonia
staphylococcu
aureu
virus
frequent
involv
sinus
common
upper
respiratori
tract
infect
may
play
pivot
role
overlap
sinus
asthma
although
previou
studi
fail
detect
presenc
virus
biopsi
sampl
sinu
mucosa
patient
chronic
rhinosinus
possibl
still
remain
viral
infect
may
provid
initi
inflammatori
stimulu
nose
possess
sever
normal
function
may
explain
relationship
nasal
diseas
lower
airway
diseas
tabl
cilia
nose
import
filter
foreign
particul
materi
includ
allergen
adjuv
may
potenti
allergen
effect
moreov
air
pass
nose
around
nasal
turbin
becom
aircondit
reduc
abil
trigger
hypersensit
reaction
nose
also
serv
humidifi
inhal
air
slow
flow
air
gener
turbin
air
nasal
turbul
help
keep
mucosa
surfac
hydrat
subsequ
breath
normal
breath
draw
air
nose
nose
patent
becom
mouth
breather
becom
mouth
breather
normal
function
nose
util
fulli
cold
dri
unfilt
air
potenti
lead
asthma
symptom
rhiniti
sicca
form
dri
nose
syndrom
atroph
rhiniti
exampl
wherebi
normal
aircondit
function
compromis
could
exacerb
serv
nidu
sinus
andor
asthma
nose
also
provid
us
sens
smell
serv
protect
mechan
avoid
area
potenti
harm
inhal
mucos
surfac
lower
upper
airway
demonstr
signific
similar
lower
upper
airway
mucosa
consist
pseudostratifi
columnar
ciliat
epithelium
cover
reticular
basement
membran
ciliat
cell
predomin
goblet
cell
triangular
basal
cell
also
popul
tracheal
bronchial
epithelium
basal
cell
small
cell
attach
basement
membran
basal
cell
lie
subepithelium
lamina
propria
blood
vessel
popul
submucosa
along
nerv
mucou
gland
inflammatori
cell
infiltr
vascular
element
bronchiol
lower
airway
also
possess
airway
smooth
muscl
cell
arrang
helic
pattern
nasal
mucosa
subepitheli
capillari
venou
cavern
sinusoid
clara
cell
uniqu
lower
airway
predomin
exist
membran
bronchiol
clara
cellspecif
protein
may
role
gener
local
inflammatori
respons
airway
tabl
trachea
bronchi
bronchiol
cartilag
start
upper
airway
gradual
becom
less
promin
toward
peripheri
lung
cshape
ring
trachea
becom
even
less
complet
ring
bronchi
disappear
bronchiolar
diamet
mm
review
gross
anatomi
upper
lower
airway
specif
compar
nose
bronchi
differ
appear
signific
similar
upper
airway
passag
within
nose
surround
rigid
framework
consist
boni
part
wherea
lower
airway
elast
easili
pliabl
tube
within
rel
flexibl
environ
may
explain
effect
treatment
lower
airway
condit
asthma
part
airway
smooth
airway
muscl
outsid
layer
pliabl
enough
respond
bronchodil
drug
wherea
upper
airway
rel
unmov
medic
evalu
upper
lower
airway
gener
initi
rigid
flexibl
nasal
rhinolaryngoscopi
nose
upper
airway
andor
bronchoscopi
lower
airway
gener
rhinolaryngoscopi
perform
otolaryngologist
allergist
pulmonologist
usual
perform
bronchoscopi
inflamm
nose
evalu
obtain
nasal
wash
biopsi
smear
examin
cellular
infiltr
sampl
obtain
bronchoscopi
may
includ
biopsi
bronchial
brush
bronchoalveolar
lavag
cultur
specimen
express
sputum
gener
vari
condit
includ
hyperton
salin
test
perform
sampl
may
includ
cytolog
histolog
mucos
surfac
identifi
inflammatori
cell
eosinophil
presenc
proinflammatori
cytokin
profil
secret
mediat
inflamm
eosinophil
cation
protein
leukotrien
prostaglandin
fiberopt
rhinolaryngoscopi
simpl
perform
present
fewer
limit
compar
bronchoscopi
limit
fiberopt
rhinolaryngoscopi
includ
inabl
scope
penetr
sinus
unless
previou
sinu
surgeri
lack
biopsi
sampl
offic
procedur
rigid
rhinoscopi
howev
allow
user
biopsi
specif
site
directli
sampl
local
suction
suspici
secret
sinu
caviti
limit
bronchoscopi
includ
inabl
scope
penetr
distal
termin
bronchiol
thu
evalu
limit
larger
lower
airway
emerg
measur
inflamm
among
medic
practition
measur
fraction
exhal
nitric
oxid
feno
like
peripher
blood
eosinophilia
ige
feno
measur
indic
system
eosinophil
inflammatori
respons
present
time
fraction
exhal
nitric
oxid
util
diagnost
monitor
tool
lower
airway
diseas
asthma
role
upper
airway
diseas
eosinophil
disord
yet
elucid
inflammatori
chang
occur
lower
upper
airway
result
atop
state
investig
studi
subject
allerg
asthma
rhiniti
subject
allerg
rhiniti
asthma
atop
subject
neither
allerg
rhiniti
allerg
asthma
nonatop
control
author
found
number
eosinophil
elev
patient
rhiniti
whether
asthma
compar
atop
nonsymptomat
group
control
group
thicken
reticular
basement
membran
upper
lower
airway
also
detect
former
two
group
manner
similar
eosinophilia
find
group
atop
individu
significantli
increas
epitheli
desquam
airway
remodel
defin
chang
structur
mucosa
submucosa
airway
specif
epitheli
fragil
thicken
reticular
basement
membran
airway
smooth
muscl
mass
increas
fibrosi
detect
lower
airway
nasal
mucosa
revers
also
true
wherebi
evid
inflammatori
marker
upper
airway
detect
patient
lower
airway
diseas
includ
nonallerg
asthma
chronic
obstruct
pulmonari
diseas
copd
nitric
oxid
marker
inflamm
attribut
lower
airway
inflamm
nasal
polyposi
studi
surgic
tissu
patient
nasal
polyp
demonstr
increas
three
isoform
nitric
oxid
synthetas
leukocyt
nasal
polyp
tissu
contrast
normal
middl
turbin
tissu
parallel
upper
lower
airway
patenc
also
studi
children
age
year
copenhagen
prospect
studi
asthma
childhood
associ
found
decongest
nasal
airway
patenc
postbronchodil
correct
confound
variabl
includ
sex
fvc
bodi
size
atop
diseas
author
propos
associ
reflect
common
physiolog
basi
comorbid
lower
upper
airway
one
mechan
propos
linkag
upper
lower
airway
system
effect
gener
allergen
exposur
nasal
passag
describ
nose
function
regul
bronchial
homeostasi
besid
physic
effect
air
characterist
nose
impart
also
function
filtrat
devic
allergen
particl
one
primari
entiti
filter
nose
nose
subject
inflammatori
effect
trigger
exposur
allergen
hypersensit
host
although
inflammatori
effect
first
local
nose
addit
studi
also
reveal
evid
system
effect
system
effect
shown
occur
mous
model
follow
induct
nasal
allerg
respons
exposur
staphylococcu
aureu
endotoxin
b
nose
shown
lead
system
releas
cytokin
includ
mous
model
addit
increas
bronchial
eosinophilia
also
detect
immunolog
uniti
also
demonstr
human
studi
correl
eosinophilia
nasal
cytolog
specimen
nasal
airflow
airway
function
detect
studi
patient
season
allerg
rhiniti
asthma
nasal
allergen
provoc
studi
show
season
nasal
introduct
grass
pollen
lead
infiltr
eosinophil
epithelium
lamina
propria
nasal
bronchial
mucosa
h
nasal
provoc
addit
increas
level
increas
percentag
vascular
endotheli
express
eselectin
detect
nasal
bronchial
mucosa
author
conclud
season
nasal
provoc
patient
grass
allergi
lead
inflammatori
infiltr
cytokin
chemokin
express
upper
lower
airway
clinic
marker
lower
airway
inflamm
follow
dust
mite
nasal
challeng
describ
studi
nonallerg
children
children
rhiniti
alon
children
rhiniti
asthma
age
year
marcucci
et
al
studi
bronchial
symptom
nasalspecif
ige
nasal
sputum
eosinophil
cation
protein
ecp
tryptas
spirometri
exhal
nitric
oxid
eno
author
conduct
nasal
challeng
begin
studi
juli
consid
low
exposur
time
end
studi
winter
consid
high
exposur
season
result
show
baselin
nasal
ige
level
higher
summertim
compar
winter
also
elev
baselin
allerg
asthmat
subject
compar
control
sputum
ecp
exhal
nitric
oxid
eno
level
respons
nasal
challeng
asthmat
mix
asthmat
experienc
increas
ecp
summer
experienc
increas
wintertim
similar
result
seen
rhiniti
patient
frequent
respons
eno
nasal
challeng
seen
winter
compar
summer
link
lower
airway
upper
airway
perhap
best
illustr
studi
observ
increas
sputum
ecp
eno
level
asthmat
children
winter
upon
nasal
challeng
dust
mite
allergen
howev
rhiniti
patient
increas
eno
detect
challeng
winter
increas
sputum
ecp
also
detect
nasal
allergen
challeng
grass
birch
pollen
nonasthmat
season
allerg
rhiniti
patient
age
cytokin
studi
includ
sicam
solubl
intracellular
adhes
molecul
author
note
peripher
blood
sputum
chang
eosinophil
placebo
allergen
challeng
plasma
level
increas
challeng
increas
correl
increas
sputum
ecp
sicam
nasal
allergen
challeng
howev
sputum
level
decreas
nasal
allergen
provoc
compar
challeng
placebo
unit
airway
theori
propos
effect
lower
upper
airway
bidirect
studi
eight
nonasthmat
grass
pollen
allerg
patient
eight
healthi
control
compar
effect
bronchoprovoc
grass
pollen
extract
nasal
bronchial
biopsi
perform
case
three
time
point
baselin
h
challeng
h
challeng
h
follow
segment
bronchial
provoc
sbp
increas
blood
eosinophil
level
allerg
patient
compar
control
suggest
system
effect
bronchial
allergen
challeng
sensit
patient
bronchial
biopsi
result
reveal
cell
eosinophil
increas
allerg
rhiniti
patient
bronchial
segment
challeng
allergen
salin
suggest
local
effect
cell
increas
local
challeng
epithelium
allerg
rhiniti
patient
well
h
post
bronchial
challeng
nasal
biopsi
reveal
number
cell
detect
nasal
lamina
propria
number
cell
nasal
epithelium
increas
allerg
rhiniti
patient
eotaxinposit
cell
also
increas
nasal
subepithelium
well
nasal
lamina
propria
allerg
patient
braunstahl
studi
effect
bronchoprovoc
sbp
mast
cell
basophil
number
nasal
bronchial
mucosa
allerg
rhiniti
patient
studi
author
found
increas
basophil
bronchial
mucosa
follow
sbp
contrast
number
chymas
mast
cell
mcc
chymasetryptas
mctc
mast
cell
decreas
nasal
mucosa
allerg
patient
wherea
number
basophil
actual
increas
author
also
note
increas
level
blood
allerg
patient
sbp
togeth
studi
support
induct
inflammatori
respons
upper
airway
respons
provoc
allergen
lower
airway
well
known
one
main
trigger
asthma
exacerb
especi
children
viral
respiratori
infect
studi
shown
virus
may
associ
asthma
exacerb
children
adult
also
demonstr
object
measur
asthma
exacerb
decreas
forc
expiratori
volum
result
infect
rhinoviru
experiment
set
chang
measur
airway
hyperrespons
inflammatori
cell
infiltr
also
describ
common
upper
respiratori
viral
infect
caus
rhinoviru
virus
incrimin
upper
respiratori
tract
infect
includ
metapneumonia
viru
enteroviru
adenoviru
respiratori
syncyti
viru
rsv
coronaviru
picornaviru
viral
infecti
diseas
affect
upper
airway
lead
lower
airway
diseas
virtu
result
interfer
normal
function
nose
howev
may
mechan
upper
respiratori
infect
affect
lower
airway
function
whether
direct
effect
viru
reach
lower
airway
system
inflammatori
effect
impact
lower
airway
clear
variou
mechan
propos
rhinoviru
fact
isol
bronchial
specimen
individu
infect
upper
airway
mechan
may
relat
inflammatori
chang
mediat
cytokin
chemokin
trigger
viral
interact
within
cellular
element
upper
respiratori
tract
immunolog
mechan
link
rhinoviru
upper
respiratori
infect
lower
respiratori
symptom
may
involv
activ
nuclear
factor
pathway
critic
mechan
activ
multipl
proinflammatori
gene
known
rhinoviru
bind
intracellular
adhes
molecul
lead
infect
airway
epitheli
cell
includ
among
mani
function
mediat
activ
upregul
adhes
molecul
known
intracellular
adhes
molecul
icam
bind
rhinoviru
allow
rhinoviru
enter
airway
epitheli
cell
lead
activ
proinflammatori
mediat
subsequ
lead
recruit
proinflammatori
cell
neutrophil
monocyt
lymphocyt
eosinophil
posit
feedback
loop
involv
upregul
express
open
door
infect
rhinoviru
result
induct
inflammatori
state
enhanc
express
multipl
proinflammatori
cytokin
includ
rant
recruit
inflammatori
cell
bronchial
tree
ultim
lead
lower
airway
inflammatori
symptom
includ
cough
wheez
dyspnea
sinc
asthma
subject
tend
cytokin
profil
skew
toward
paradigm
rhinoviru
infect
upper
airway
may
result
lower
product
reduct
may
accentu
lower
airway
involv
asthma
also
shown
granulocyt
colonystimul
factor
gcsf
level
increas
local
nose
system
circul
allerg
subject
subject
experiment
infect
increas
gcsf
level
lead
higher
neutrophil
count
activ
may
play
role
increas
inflammatori
state
site
distant
upper
airway
cell
may
stimul
infiltr
lower
airway
includ
eosinophil
lymphocyt
monocyt
macrophag
effect
viral
infect
extend
select
nonasthmat
subject
respiratori
diseas
well
adult
exacerb
copd
link
upper
respiratori
infect
chronic
rhinosinus
without
nasal
polyp
associ
inflammatori
state
involv
increas
serum
increas
eosinophilia
within
bone
marrow
immunolog
pattern
similar
seen
asthma
also
parallel
cytokin
profil
sinu
tissu
patient
chronic
rhinosinus
bronchial
tissu
patient
asthma
histolog
find
chronic
rhinosinus
includ
epitheli
shed
thicken
basement
membran
hallmark
asthmat
bronchiti
eosinophil
degranul
releas
mediat
eosinophil
cation
protein
demonstr
occur
nose
lower
airway
patient
sinus
asthma
cytokin
known
effect
asthma
proinflammatori
cytokin
releas
cell
thought
involv
neutrophil
infiltr
bronchial
tissu
patient
asthma
saitoh
et
al
demonstr
increas
nasal
polyp
compar
normal
sinu
tissu
correl
increas
eosinophil
lymphocyt
also
abl
correl
extent
basement
membran
thicken
level
observ
suggest
common
role
upper
lower
airway
interest
observ
abil
fungi
gener
inflammatori
airway
diseas
allerg
bronchopulmonari
aspergillosi
lung
allerg
fungal
sinus
sinus
support
concept
unifi
upper
lower
respiratori
tract
pakdaman
et
al
review
possibl
role
fungi
superantigen
adjunct
enhanc
inflammatori
respons
suggest
similar
histomorpholog
upper
lower
airway
present
common
target
fungi
review
discuss
fungi
may
initi
inflammatori
insult
lead
chronic
airway
inflamm
japanes
studi
investig
cytokin
profil
patient
chronic
rhinosinus
nasal
polyp
compar
patient
without
nasal
polyp
normal
control
found
elev
level
eosinophil
cation
protein
ecp
staphylococc
enterotoxinig
saeig
ige
group
rhinosinus
nasal
polyp
polyp
group
demonstr
skew
toward
cytokin
profil
rel
lower
level
group
rhinosinus
without
nasal
polyp
demonstr
higher
level
suggest
profil
interest
compon
small
studi
fact
patient
rhinosinus
nasal
polyp
asthma
none
group
without
polyp
asthma
paper
compar
histolog
morpholog
differ
nasal
polyp
asthma
rais
interest
question
concern
uniqu
infrequ
polyp
lung
compar
upper
airway
mucosa
organ
system
mucos
surfac
gastrointestin
urinari
tract
lung
mucosa
render
less
prone
develop
polyp
author
suggest
observ
could
explain
compar
differ
mucos
characterist
nose
lung
one
factor
stand
play
import
role
remodel
process
epitheli
injuri
result
increas
upregul
asthmat
downregul
nasal
polyposi
hand
presenc
lung
prevent
develop
polyp
nose
nasal
reticular
basement
membran
becom
less
thicken
featur
nasal
polyposi
incident
also
play
protect
role
develop
benign
polyp
larg
intestin
well
mutat
disrupt
signal
pathway
juvenil
polyposi
syndrom
nasobronchi
nasopharyng
reflex
mechan
mention
support
unifi
airway
health
diseas
bucca
report
increas
lower
airway
hyperrespons
occur
patient
sinus
patient
increas
airway
hyperrespons
also
includ
extrathorac
airway
hyperrespons
measur
author
suggest
mechan
occur
activ
nasopharyngealbronchi
reflex
studi
nonasthmat
patient
sinus
investig
relationship
pharyng
mucos
chang
bronchial
hyperrespons
author
use
histamin
threshold
bronchial
respons
threshold
extrathorac
airway
hyperrespons
patient
found
epitheli
thin
repres
pharyng
mucosa
damag
correl
extrathorac
airway
hyperrespons
bronchial
hyperrespons
also
associ
longstand
sinus
increas
submucos
nerv
densiti
increas
eosinophil
nasal
lavag
fluid
lower
author
interpret
result
indic
pharyng
damag
contribut
airway
dysfunct
stimul
mucos
nerv
end
activ
constrict
reflex
lead
increas
extrathorac
airway
hyperrespons
also
postul
pharyng
damag
failur
normal
physiolog
filter
function
grant
access
irrit
allergen
submucos
nerv
end
whether
nasal
secret
stimul
lower
airway
inflammatori
respons
direct
contact
matter
great
debat
intuit
seem
make
sens
postnas
drip
facilit
graviti
end
lower
airway
mucou
contain
allerg
inflammatori
mediat
inflammatori
respons
lower
airway
expect
howev
two
separ
studi
nasal
applic
radioactivelabel
allergen
show
deposit
digest
tract
lower
respiratori
tract
contrast
studi
support
concept
cough
associ
postnas
drip
suggest
altern
mechan
effect
upper
airway
secret
lower
airway
inflamm
possibl
aspir
stomach
content
may
respons
cough
patient
stimul
pharyngolaryng
receptor
inflammatori
mediat
eman
may
key
mechan
postnas
driprel
cough
summari
potenti
pathogen
mechan
behind
link
upper
lower
airway
illustr
fig
aspirinexacerb
respiratori
diseas
aerd
also
known
previous
samter
triad
describ
perenni
condit
compris
three
compon
name
aspirin
sensit
asthma
chronic
rhinosinus
nasal
polyposi
rhinitisnas
polyposi
symptom
includ
rhinorrhea
nasal
congest
sneez
anosmia
asthma
chronic
rhinosinus
aerd
character
eosinophil
infiltr
mucosa
correspond
tissu
aspirininduc
asthma
surprisingli
common
phenomenon
data
suggest
preval
aspirininduc
asthma
much
higher
adult
children
vs
asthma
usual
diagnos
year
onset
upper
airway
symptom
commonli
difficult
treat
nasal
polyp
recurr
frequent
requir
multipl
surgeri
aspirin
sensit
usual
occur
patient
previous
abl
toler
aspirin
aspirin
nonsteroid
antiinflammatori
drug
nsaid
mode
action
inhibit
cyclooxygenas
result
inhibit
increas
substrat
arachidon
acid
lead
increas
activ
lipoxygenas
pathway
releas
leukotrien
circul
surround
tissu
leukotrien
potent
mediat
inflamm
detail
aspirinexacerb
respiratori
diseas
discuss
chapter
book
discuss
focu
mechan
predispos
patient
diseas
upper
lower
airway
context
unifi
airway
diseas
respiratori
tract
mast
cell
secretori
cell
respiratori
tract
releas
leukotrien
upon
stimul
synthas
key
enzym
catalyz
synthesi
leukotrien
bind
leukotrien
receptor
trigger
inflammatori
mediat
releas
found
upregul
patient
aerd
cell
reduc
intranas
desensit
aspirin
high
cysteinyl
leukotrien
level
accompani
low
product
prostaglandin
downregul
nasal
polyp
aspirinsensit
patient
eosinophil
nasal
polyp
aerd
patient
show
increas
express
synthas
airway
excess
product
cysteinyl
leukotrien
lead
induct
airway
smooth
muscl
contract
increas
vascular
permeabl
airway
remodel
abnorm
arachidon
acid
pathway
mechan
induct
effect
occur
nasal
polyp
tissu
level
prostaglandin
receptor
express
reduc
airway
leukocyt
asthmat
patient
aspirin
sensit
eosinophil
bronchial
biopsi
patient
asthma
also
demonstr
increas
synthas
togeth
observ
common
patholog
featur
mucosa
nasal
polyp
asthma
support
common
suscept
distant
part
airway
sever
autoimmun
diseas
involv
upper
lower
airway
specif
sinus
lung
includ
wegen
granulomatosi
churgstrauss
syndrom
type
autoimmun
diseas
affect
lung
thought
relat
smallvessel
vasculitid
whether
involv
lung
sinus
condit
strictli
function
vascular
patholog
mechan
would
impact
part
airway
known
gastroesophag
reflux
shown
comorbid
condit
asthma
earli
william
osler
identifi
link
gastrointestin
respiratori
system
note
over
induc
cough
paroxysm
asthmat
gener
major
asthmat
subject
describ
symptom
reflux
similarli
mani
patient
asthma
complain
respiratori
symptom
relat
reflux
even
day
yet
clear
asthma
caus
reflux
vice
versa
studi
upper
airway
obstruct
gastroesophag
reflux
perform
dog
suggest
upper
airway
obstruct
caus
gastroesophag
reflux
gener
neg
inspiratori
pressur
tempor
show
induct
airway
obstruct
led
gastroesophag
reflux
week
creation
obstruct
abnorm
pressur
esophagu
airway
obstruct
predispos
patient
reflux
explain
bernoulli
principl
bernoulli
principl
state
invers
relationship
veloc
fluid
tube
pressur
exert
perpendicularli
fluid
hand
suggest
gastroesophag
reflux
trigger
asthma
aspirationinduc
inflamm
result
hyperrespons
airway
support
concept
review
literatur
suggest
treatment
symptomat
gastroesophag
reflux
improv
asthma
symptom
howev
valid
case
silent
asymptomat
gastroesophag
reflux
effect
reflux
asthma
thu
remain
unclear
probabl
put
two
event
togeth
produc
viciou
cycl
one
diseas
exacerb
treatment
either
diseas
break
cycl
improv
symptom
critic
review
literatur
focus
analyz
three
concept
support
evid
role
ger
sinus
firstli
author
note
higher
preval
gastroesophag
reflux
exist
patient
hardtotreat
sinus
secondli
review
pathogen
mechan
ger
sinus
abl
formul
plausibl
explan
relationship
part
evid
includ
observ
gastric
acid
content
found
middl
ear
patient
otiti
media
effus
addit
wong
et
al
show
hyperact
reflux
induc
autonom
nervou
system
lead
sinonas
edema
compromis
normal
drainag
chronic
rhinosinus
previous
describ
pinto
et
al
thirdli
patient
success
treatment
gastroesophag
reflux
experienc
higher
degre
resolut
sinu
symptom
global
wellb
author
present
algorithm
involv
use
acidlow
drug
like
proton
pump
inhibitor
treatment
sinus
independ
relationship
gastroesophag
reflux
asthma
sinus
suggest
common
suscept
throughout
entir
respiratori
tract
content
stomach
exact
mechan
effect
unknown
correl
seem
support
one
airway
one
diseas
model
interest
extens
one
airway
one
diseas
concept
relat
link
rhiniti
laryng
studi
allerg
rhiniti
patient
nonallerg
rhiniti
patient
normal
control
demonstr
patient
either
allerg
nonallerg
rhiniti
markedli
signific
higher
rate
dysphonia
patient
without
rhiniti
respect
presenc
asthma
use
inhal
corticosteroid
confound
variabl
control
studi
curious
howev
use
intranas
corticosteroid
presum
either
exclus
criteria
variabl
would
control
specif
mention
paper
earlier
report
also
note
allerg
rhiniti
patient
may
benefit
immunotherapi
least
three
time
like
dysphonia
normal
control
investig
also
propos
link
vocal
cord
problem
allerg
rhiniti
symptom
may
may
simpli
attribut
postnas
drainag
relationship
sinus
voic
abnorm
also
propos
paramet
necessari
evalu
vocal
characterist
sinus
patient
establish
although
differ
paramet
detect
pilot
studi
chronic
sinus
control
subject
author
propos
least
patient
would
need
conduct
studi
would
demonstr
reliabl
statist
valid
result
treatment
allerg
rhiniti
medic
led
interest
observ
regard
effect
drug
also
treat
asthma
effect
treatment
allerg
rhiniti
associ
reduc
frequenc
emerg
depart
visit
asthma
reduc
risk
hospit
asthma
antihistamin
use
treat
allerg
rhiniti
may
benefit
asthma
glucocorticoid
cours
treat
area
respiratori
tract
appli
topic
region
perhap
interest
effect
immunotherapi
asthma
believ
immunotherapi
work
system
basi
modul
immun
system
one
might
infer
immunotherapi
use
treat
allerg
rhiniti
help
allerg
asthma
well
fact
numer
studi
support
role
immunotherapi
asthma
illustr
parallel
strategi
treatment
allerg
rhiniti
asthma
shown
tabl
numer
studi
pediatr
popul
suggest
treatment
sinus
patient
concurr
asthma
lead
rapid
resolut
exacerb
discuss
role
leukotrien
pathway
medic
import
exist
diseas
complex
known
samter
triad
consist
nasal
polyposi
aspirin
sensit
sever
asthma
refer
aspirinexacerb
respiratori
diseas
aerd
role
aspirin
sinus
discuss
chapter
aspirininduc
sinu
diseas
leukotrien
receptor
antagonist
montelukast
found
efficaci
treatment
allerg
rhiniti
asthma
leukotrien
receptor
antagonist
also
found
play
role
treatment
chronic
sinus
conclus
mostli
establish
studi
leukotrien
receptor
antagonist
treatment
aerd
wherebi
asthma
intend
indic
chronic
sinus
unintend
consequ
shown
improv
chronic
sinus
eosinophil
mast
cell
commonli
implic
cell
type
inhibit
proinflammatori
activ
eosinophil
shown
reduc
level
found
effect
treatment
nasal
polyp
propos
therapi
asthma
virtu
potenti
effect
decreas
level
shown
abl
increas
receptor
level
eosinophil
lymphocyt
thu
target
cytokin
pathway
may
mean
reduc
effect
leukotrien
pilot
studi
mepolizumab
treatment
sinus
churgstrauss
syndrom
led
improv
seven
patient
month
treatment
withdraw
drug
led
revers
benefici
effect
mepolizumab
addit
target
cytokin
gener
eosinophil
mast
cell
imatinib
tyrosin
kinas
inhibitor
also
found
directli
inhibit
activ
function
cell
line
studi
eight
patient
chronic
hypereosinophil
sinus
show
imatinib
could
lead
decreas
eosinophil
blood
subject
symptom
improv
half
subject
one
risk
factor
advers
reaction
immunotherapi
asthma
howev
immunotherapi
also
associ
improv
asthma
fact
observ
may
support
exist
one
airway
one
diseas
paradigm
sinc
benefit
mode
therapi
extend
upper
lower
airway
omalizumab
recombin
human
monoclon
antibodi
primarili
class
direct
ige
omalizumab
first
develop
treatment
moder
sever
persist
asthma
howev
also
studi
treatment
upper
airway
allerg
rhiniti
well
random
control
trial
studi
effect
omalizumab
allerg
rhiniti
symptom
conduct
patient
age
year
outcom
measur
includ
selfassess
daili
nasal
symptom
score
antihistamin
use
qualityoflif
assess
free
ige
level
also
measur
result
indic
omalizumab
effect
mode
therapi
improv
three
outcom
measur
increas
advers
side
effect
note
treatment
group
compar
placebo
group
similar
result
found
studi
use
omalizumab
birch
pollen
cedar
polleninduc
season
allerg
rhiniti
lower
airway
holgat
et
al
show
omalizumab
similar
benefici
effect
asthma
patient
like
abl
reduc
inhal
corticosteroid
usag
accompani
reduct
asthmarel
hospit
emerg
room
visit
qualityoflif
improv
also
detect
innov
studi
one
earlier
studi
effect
omalizumab
allerg
asthma
benefici
effect
seen
common
throughout
respiratori
tract
upper
lower
airway
suggest
common
mechan
target
singl
agent
classif
asthma
variou
categori
base
risk
control
ongo
project
sinc
earli
sever
iter
guidelin
recent
version
focus
impair
risk
control
medic
rescu
medic
rel
clearli
delin
treatment
manag
algorithm
introduc
assist
physician
caregiv
recent
similar
set
classif
guidelin
also
introduc
treatment
allerg
rhiniti
well
recent
version
guidelin
introduc
put
forth
grade
recommend
assess
develop
evalu
grade
work
group
allerg
rhiniti
impact
asthma
aria
guidelin
panel
review
system
review
best
avail
evid
approach
classifi
allerg
rhiniti
asthma
remark
similar
probabl
design
reflect
similar
two
diseas
first
categor
intermitt
persist
persist
form
divid
mild
moder
sever
group
firstlin
treatment
topic
either
inhal
intranas
corticosteroid
reflect
need
provid
antiinflammatori
control
base
patholog
observ
alreadi
discuss
mainten
medic
includ
leukotrien
receptor
antagonist
montelukast
zafirlukast
pranlukast
class
effect
may
variabl
effect
treat
symptom
lower
upper
respiratori
tract
antihistamin
use
allerg
rhiniti
role
allerg
asthma
quit
clear
overal
parallel
current
recommend
treatment
upper
lower
airway
allerg
diseas
nearli
ident
illustr
tabl
given
prudenc
one
airway
one
diseas
theori
prospect
studi
asthma
patient
also
nasal
polyposi
conduct
investig
whether
surgic
treatment
nasal
diseas
led
improv
asthma
studi
last
week
variou
asthmarel
paramet
evalu
therapeut
endpoint
upper
airway
paramet
includ
subject
measur
nasal
congest
rhinorrhea
object
measur
peak
nasal
inspiratori
flow
lower
airway
paramet
includ
symptom
asthma
cough
dyspnea
along
object
test
includ
peak
expiratori
flow
rate
measur
lung
function
test
studi
includ
adult
patient
also
evalu
use
fluticason
propion
nasal
spray
prior
surgeri
doubleblind
random
control
format
result
studi
indic
function
endoscop
sinu
surgeri
led
signific
improv
upper
lower
airway
symptom
well
improv
object
measur
part
airway
inclus
doubleblind
random
control
trial
presurg
fluticason
confound
data
somewhat
answer
question
investig
regard
effect
presurg
use
nasal
steroid
improv
surgic
outcom
recent
studi
evalu
whether
improv
asthma
sustain
function
endoscop
sinu
surgeri
fiftyon
adult
patient
nasal
polyposi
asthma
underw
function
endoscop
surgeri
improv
subject
object
lower
upper
airway
paramet
occur
immedi
surgeri
maintain
year
post
surgeri
anoth
studi
provid
longterm
data
averag
year
patient
asthma
underw
function
endoscop
sinu
surgeri
subject
object
paramet
asthma
sever
record
includ
util
hospit
visit
medic
use
clinic
symptom
sustain
improv
note
paramet
corollari
note
benefit
sinu
surgeri
improv
asthma
demonstr
studi
patient
chronic
rhinosinus
underw
revis
endoscop
sinu
surgeri
studi
show
biofilmform
bacteria
asthma
independ
associ
risk
refractori
chronic
rhinosinus
requir
revis
endoscop
surgeri
would
suggest
treatment
asthma
may
import
factor
determin
efficaci
surgic
treatment
sinu
diseas
illustr
bidirect
natur
associ
asthma
sinu
diseas
difficulttotreat
asthma
may
result
failur
recogn
treat
comorbid
condit
associ
asthma
may
includ
allerg
rhiniti
perenni
rhiniti
nonallerg
rhiniti
eosinophilia
viral
bronchiti
pneumonia
atelectasi
chronic
postnas
drip
gastroesophag
reflux
obstruct
sleep
apnea
rhinosinus
relationship
illustr
fig
algorithm
depict
approach
treatment
difficult
asthma
shown
fig
ancient
time
physician
appreci
connect
upper
airway
lower
airway
throughout
histori
link
consolid
understand
pathogen
mechan
behind
link
cultiv
longer
simpli
intuit
presum
relationship
sever
mechan
play
involv
neural
vascular
immunolog
physic
pathway
known
anatom
histomorpholog
similar
upper
lower
airway
would
lead
one
believ
effect
one
part
airway
duplic
part
howev
also
differ
upper
lower
airway
relationship
upper
lower
airway
may
fact
mediat
multitud
factor
nasobronchi
reflex
may
trigger
vascular
chang
two
part
airway
allergen
challeng
one
part
airway
may
trigger
local
chang
lead
similar
chang
part
airway
may
also
mediat
inflammatori
effect
system
inflammatori
respons
lead
infiltr
inflammatori
cell
gener
inflammatori
cytokin
distant
site
shown
may
involv
action
cytokin
cytokin
may
actual
provid
protect
effect
similar
cytolog
chang
nasal
polyp
tissu
lower
airway
tissu
polyp
often
seen
lower
airway
research
patholog
mechan
upper
lower
airway
inflamm
bring
better
understand
similar
differ
inflamm
two
area
contigu
organ
hope
lead
better
safer
therapeut
modal
